Title: Clinical and Translational Science Strategic Plan CSP
1Clinical and Translational Science Strategic
Plan (CSP)
- Just ideas for discussion
2Each academic health center will create a home
for clinical and translational science
NIH other government agencies
Clinical Research Ethics
Trial Design
Advanced Degree-Granting Programs
Biomedical Informatics
CTSA HOME
Industry
Participant Community Involvement
Clinical Resources
Biostatistics
Regulatory Support
Healthcare organizations
3Key orientation for CSP
- What can the consortium accomplish as a
unified/federated organization beyond the impact
of the individual sites?
4Key Components of a Strategic Plan
- Mission
- Vision
- Goals
- Tactics
- Manual of Operations (MOP)
- Communication plan
- Evaluation plan
- Budget and funding
5Clinical and Translational Science Awards
- The Clinical and Translational Science Awards
(CTSAs) is a consortium that is transforming how
clinical and translational research is conducted,
ultimately enabling researchers to provide new
treatments more efficiently and quickly to
patients. - The consortium is designed to
- Encourage the development of new methods and
approaches to clinical and translational research
- Improve training and mentoring to ensure that new
investigators can navigate the increasingly
complex research system - Design new and improved clinical research
informatics tools - Assemble interdisciplinary teams that cover the
complete spectrum of medical research - Forge new partnerships with private and public
health care organizations
6Who Cares about the CTSA CSP?
- Primary Players CTSA PIs and NCRR
- Key Partners
- Consortium committees
- NIH Institutes
- Key constituents
- Institutional officials for CTSA recipients
- NIH leadership
- Faculty at CTSA recipients
- Rest of clinical and translational research world
- Congress, industry, professional societies and
organizations, the public, the press
7Consortium Oversight Committee (COCC)
- Responsible for driving the process of developing
the CSP - Discussing on weekly conference calls
- Organizing input/writing the plan
- Deciding when iterations are needed with partners
and constituents - Crafting penultimate version for approval by COCC
8COCC Members
- COCC Co-Chairs (currently Berglund and Califf)
- NCRR leadership (currently Alving and Hayward)
- PI members
- NIH members
9NCRR Role
- Provides ideas and concepts for CSP
- Discusses drafts of plan for iterative input
- Has input into all aspects
- Approves through COCC
- Iteratively deals with consonance of plan with
funding availability and allowable mechanisms of
funding
10PI Role
- Provides ideas and concepts for CSP
- Discusses drafts of plan for iterative input
- Has input into all aspects,
- Approves through COCC
- Has key input into feasibility of implementation
of vision given institutional opportunities and
constraints - Monitors and communicates need for updates
through COCC
11Consortium Committees
- Represented by Co-Chairs and PI liasons
- Asked for input to vision and mission statements
early on - Asked for ideas about key priorities and needs
prior to consortium wide retreat - Review and comment on product of retreat
- Review and comment on drafts of CSP
12NIH Institutes
- Represented by NIH appointed and PI liasons
- Asked for input to vision and mission statements
early on - Asked for ideas about key priorities and needs
prior to consortium wide retreat - Review and comment on product of retreat
- Review and comment on drafts of CSP
13Thoughts on Key Constituents
- Institutional officials
- Existential issue of role of CTSA within
institutions (transforming or on the shelf?) - Need to get these folks involved
- NIH leadership
- How do we deal with likelihood of new
administration? - Importance of clear CTSA consensus on value
- Faculty
- We are challenged to assure that we are
communicating effectively with our own faculty - This is a chance to do it
14Thoughts on Rest of World
- Congress, the press, the public
- Communication methods very similar for these 3
elements - Should they be involved and how?
- Professional organizations and professions
- Too many to count
- Should they be involved and how?
- Industry
- IT, devices, drugs, payers, providers, etc
- Prediction private money will be more important
no matter who gets elected so rules of
engagement will be critical
15Process for Strategic Plan
- Use face to face meeting of COCC to begin
discussion of mission, vision and goals - Retreat of operations committee shortly after
face to face meeting - Ask each committee to come up with list of what
it believes the consortium should be doing - Big Bang CSP retreat of PIs and NCRR leaders
with reps of other key constituents - Work towards plan agreement within 2 cycles of
face to face meetings - Treat the CSP as a living document
16Impetus for the CTSA Program
- Implementing biomedical discoveries made in the
last 10 years demands an evolution of clinical
science. - New prevention strategies and treatments must be
developed, tested, and brought into medical
practice more rapidly. - CTSA awards will lowerĀ barriers between
disciplines,Ā and encourage creative, innovative
approaches to solve complex medical problems. - These clinical and translational science awards
will catalyze change -- breaking silos, breaking
barriers, and breaking conventions.
17Building a National CTSA Consortium
WA
ME
MT
ND
VT
MN
OR
NH
ID
WI
NY
MA
SD
WY
MI
RI
CT
NJ
IA
PA
NE
NV
OH
DE
IL
IN
UT
MD
CO
WV
VA
KS
MO
CA
KY
TN
AZ
OK
AR
SC
NM
GA
AL
MS
TX
LA
AK
FL
HI
Participating Institutions
Since 2006 Since 2007
18Building a National CTSA Consortium
FY06 Grantees Center for Clinical and
Translational ScienceThe Rockefeller University
Center for Clinical and Translational
SciencesUniversity of Texas Health Sciences
Center at Houston Clinical and Translational
Science CenterUniversity of California,
Davis Clinical and Translational Science
InstituteUniversity of Pittsburgh Clinical and
Translational Science Institute University of
California, San Francisco Clinical and
Translational Sciences InstituteUniversity of
Rochester School of Medicine and Dentistry Duke
Clinical and Translational Science InstituteDuke
University Institute for Translational Medicine
and TherapeuticsUniversity of Pennsylvania Irving
Institute for Clinical and Translational
Research Columbia University Mayo Center for
Translational Science ActivitiesMayo Clinic
Oregon Clinical and Translational Research
InstituteOregon Health and Science University
(partnering with Kaiser Permanente) Yale Center
for Clinical InvestigationYale University
FY07 Grantees Atlanta Clinical and Translational
Science Institute Emory University (partnering
with Morehouse College) CTSA at Case Western
UniversityCase Western University CTSA at
Washington University Washington University CTSA
at Weill Cornell Medical College Weill Cornell
Medical College (partnering with Hunter
College) Institute for Clinical and Translational
ResearchUniversity Of Wisconsin
Madison Institute for Clinical and Translational
Research Johns Hopkins Institute of
Translational Health Sciences University Of
Washington Michigan Institute of Clinical and
Health Research University Of Michigan At Ann
Arbor North Central Texas Clinical and
Translational Science Initiative University of
Texas Southwestern Medical Center -
Dallas University Of Chicago CTSAUniversity Of
Chicago Univ of Iowa's Inst for Clinical and
Translational Science University Of
Iowa Vanderbilt Institute for Clinical and
Translational Research Vanderbilt University
(partnering with Meharry Medical College)
19Consortium Governance Organization
Governance Manual available at http//ctsaweb.org/
Docs/CTSA_Governance_Manual.pdf
20CTSAWeb.org
21CTSA Publication Policy
22CTSA Publication Policy
- Publications emanating from an individual CTSA
- With direct CTSA funding of personnel
- With infrastructure support
- CTSA associated
23CTSA Publication Policy
- Publications reflecting opinions about CTSA
24CTSA Publication Policy
- Publications reflecting official view of CTSA
Consortium - With NIH and PI participation
- With NIH, but not PI participation
- With PI, but not NIH participation